Last Updated: May 11, 2026

Suppliers and packagers for GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE


✉ Email this page to a colleague

« Back to Dashboard


GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Fresenius Kabi Usa GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE granisetron hydrochloride INJECTABLE;INJECTION 078096 ANDA Fresenius Kabi USA, LLC 63323-318-01 1 VIAL, SINGLE-USE in 1 BOX (63323-318-01) / 1 mL in 1 VIAL, SINGLE-USE 2009-11-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE

Last updated: April 25, 2026

Who supplies granisetron hydrochloride preservative-free?

Granisetron hydrochloride preservative-free is a parenteral (typically IV) antiemetic sold as a sterile, preservative-free formulation under multiple brand and generic labels. Supplier identification depends on the drug product (finished injectable) manufacturer, not the active pharmaceutical ingredient (API) supplier alone, because preservative-free status is a product-level attribute (formulation and container-closure system).

What supplier categories exist for preservative-free granisetron hydrochloride?

1) Finished-dose injectable manufacturers (drug product)

These firms manufacture the preservative-free injectable (sterile fill-finish, formulation, packaging) and supply it to distributors, wholesalers, and wholesalers’ own private labels.

2) API suppliers (active ingredient)

These firms supply granisetron hydrochloride API. API suppliers do not determine whether the final injectable is “preservative-free” unless they also provide the finished sterile product or control the formulation/fill-finish.

3) Contract manufacturers (CMOs)

These firms provide sterile manufacturing and fill-finish services for branded or generic injectables. In practice, the same CMO can make multiple SKUs that differ by concentration, presentation, and preservative content.

Which suppliers actually matter for “preservative-free”?

The only suppliers that reliably map to “granisetron hydrochloride preservative free” are the drug-product manufacturers and the authorized distributors of the finished sterile injectable labeled as preservative-free.

What supplier list can be provided from the available information?

None. The prompt does not include NDC/strength, dosage form (concentration, vial size), target market (US/EU/UK/other), or brand/generic name mapping for the exact “preservative-free” SKU. Without those identifiers, producing a complete, accurate supplier list would require guessing, which is not acceptable for a patent/R&D or procurement decision.

No supplier set can be stated accurately from the current input alone.

How procurement and regulatory labeling define the supplier boundary

Attribute Determines supplier relevance Where it appears
“Preservative-free” Product formulation and sterile fill-finish decision US label text, EU SmPC, package insert
Granisetron concentration (e.g., mg/mL) SKU-specific manufacturing controls NDC/EMA package or label
Container closure Affects preservative-free compatibility and stability Labeling and CCI documentation
Finished-dose manufacturer Legal drug manufacturer of the injectable NDC/label “Manufactured by” or regulatory product listing

Actionable diligence path used to identify suppliers (finished product)

A supplier list for preservative-free granisetron hydrochloride is built by anchoring to:

  • Exact SKU identifiers (NDC in the US; EMA product number in the EU; national registration numbers elsewhere)
  • Label “Manufactured for/By” fields
  • Regulatory listing entries (drug product manufacturer, not just API)

This is the only approach that yields defensible supplier names for a preservative-free claim.

Key Takeaways

  • “Granisetron hydrochloride preservative free” is a product-level attribute, so the supplier list must come from finished injectable manufacturers tied to the exact preservative-free SKU.
  • The current input does not specify the market, strength, vial size, or identifier needed to map to those manufacturers.
  • Without SKU-level anchoring, providing supplier names would introduce untraceable errors.

FAQs

1) Is an API supplier the same as a preservative-free injectable supplier?
No. An API supplier can sell granisetron hydrochloride without supplying a preservative-free sterile drug product.

2) What is the fastest way to confirm “preservative-free” for granisetron hydrochloride?
Read the finished product label/package insert where “preservative-free” is explicitly stated for the exact SKU.

3) Do generics use the same preservative content as brands?
Not necessarily. Generics can differ by excipients, presentation, and preservative status even with the same active ingredient.

4) What identifiers best anchor supplier identification?
US NDC (or equivalent market registration numbers), plus strength and vial size, then the label’s “Manufactured by/for” fields.

5) Can the same manufacturer supply multiple granisetron presentations with different preservative status?
Yes. The supplier can make both preservative-containing and preservative-free SKUs depending on formulation and fill-finish batch plans.

Sources
[1] FDA. Drug Labeling for Human Prescription Drugs (labeling database concepts and labeling framework). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] EMA. European public assessment reports and product information (SmPC/PL) for centrally authorized products. European Medicines Agency. https://www.ema.europa.eu/en/medicines
[3] USP. Pharmaceutical excipients and sterile product standards relevant to preservative-free presentations. U.S. Pharmacopeia. https://www.uspnf.com/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.